Raquel Torres

1.2k total citations · 1 hit paper
8 papers, 693 citations indexed

About

Raquel Torres is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Raquel Torres has authored 8 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Raquel Torres's work include Advanced Breast Cancer Therapies (5 papers), Cancer-related Molecular Pathways (5 papers) and HER2/EGFR in Cancer Research (2 papers). Raquel Torres is often cited by papers focused on Advanced Breast Cancer Therapies (5 papers), Cancer-related Molecular Pathways (5 papers) and HER2/EGFR in Cancer Research (2 papers). Raquel Torres collaborates with scholars based in Spain, United States and United Kingdom. Raquel Torres's co-authors include Marı́a José Lallena, Alfonso de Dios, Emiko L. Kreklau, Damien M. Cronier, Shufen Cai, Blake Lee Neubauer, Jamie Young, Rose T. Ajamie, Miriam Del Prado and Concepción Sánchez‐Martínez and has published in prestigious journals such as Cancer Research, Molecular Cancer Therapeutics and Frontiers in Oncology.

In The Last Decade

Raquel Torres

8 papers receiving 679 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine

2014 446 citations Lawrence M. Gelbert, Shufen Cai et al. Investigational New Drugs profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raquel Torres Spain	6	416	412	170	141	137	8	693
H Schweisfurth Germany	14	271 0.7×	249 0.6×	148 0.9×	32 0.2×	82 0.6×	39	572
Sachindra Raj Joshi United States	16	334 0.8×	56 0.1×	330 1.9×	42 0.3×	166 1.2×	35	769
Emma Du United States	12	55 0.1×	152 0.4×	238 1.4×	101 0.7×	39 0.3×	16	586
Xiao‐Dong Jiao China	17	338 0.8×	383 0.9×	291 1.7×	24 0.2×	25 0.2×	56	821
Chen Huang China	16	128 0.3×	271 0.7×	326 1.9×	17 0.1×	50 0.4×	38	843
André Vasconcelos Portugal	13	128 0.3×	153 0.4×	293 1.7×	26 0.2×	65 0.5×	13	569
Wei‐Hwa Lee Taiwan	11	86 0.2×	123 0.3×	209 1.2×	40 0.3×	21 0.2×	26	464
Hai Li China	9	110 0.3×	121 0.3×	130 0.8×	19 0.1×	54 0.4×	19	356
Petros Giannikopoulos United States	8	212 0.5×	157 0.4×	213 1.3×	15 0.1×	36 0.3×	17	454
Isabell Seitz Germany	10	46 0.1×	43 0.1×	257 1.5×	83 0.6×	184 1.3×	11	554

Countries citing papers authored by Raquel Torres

Since Specialization

Citations

This map shows the geographic impact of Raquel Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquel Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquel Torres more than expected).

Fields of papers citing papers by Raquel Torres

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raquel Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquel Torres. The network helps show where Raquel Torres may publish in the future.

Co-authorship network of co-authors of Raquel Torres

This figure shows the co-authorship network connecting the top 25 collaborators of Raquel Torres. A scholar is included among the top collaborators of Raquel Torres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raquel Torres. Raquel Torres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Marugán, Carlos, Raquel Torres, & Marı́a José Lallena. (2016). Phenotypic Screening Approaches to Develop Aurora Kinase Inhibitors: Drug Discovery Perspectives. Frontiers in Oncology. 5. 299–299. 5 indexed citations

2.

Torres, Raquel, Bruna Calsina, Ana Hermoso, et al.. (2016). Abstract 2836: Characterization of the mechanism of action for abemaciclib with antiestrogen combined therapy in human breast cancer cell lines. Cancer Research. 76(14_Supplement). 2836–2836. 3 indexed citations

3.

Burke, Teresa F., Raquel Torres, Ann M. McNulty, et al.. (2016). Abstract 2830: The major human metabolites of abemaciclib are inhibitors of CDK4 and CDK6. Cancer Research. 76(14_Supplement). 2830–2830. 13 indexed citations

4.

Lallena, Marı́a José, Karsten Boehnke, Raquel Torres, et al.. (2015). Abstract 3101: In-vitro characterization of Abemaciclib pharmacology in ER+ breast cancer cell lines. Cancer Research. 75(15_Supplement). 3101–3101. 21 indexed citations

5.

Gelbert, Lawrence M., Shufen Cai, Xi Lin, et al.. (2014). Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine. Investigational New Drugs. 32(5). 825–837. 446 indexed citations breakdown →

6.

Gelbert, Lawrence M., Shufen Cai, Xi Lin, et al.. (2011). Abstract B233: Identification and characterization of LY2835219: A potent oral inhibitor of the cyclin-dependent kinases 4 and 6 (CDK4/6) with broad in vivo antitumor activity.. Molecular Cancer Therapeutics. 10(11_Supplement). B233–B233. 14 indexed citations

7.

O'Steen, Barbara E., X. Silver, Raquel Torres, et al.. (2006). Alpha-II-Spectrin after Controlled Cortical Impact in the Immature Rat Brain. Developmental Neuroscience. 28(4-5). 457–465. 26 indexed citations

8.

Díez-Freire, Carlos, Jorge Vázquez, M Ferrari, et al.. (2006). ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. Physiological Genomics. 27(1). 12–19. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact